“With the US healthcare reforms, spending will go up and so will the number of people engaged in execution. IT outsourcing will also go up, despite the government’s protectionist attitude. A significant amount of work will come to India. Ness is bullish about bagging some of the projects,” said Mr Satyajit Bandopadhyay, President and Managing Director, Ness Technologies (NASDAQ:NSTC) (India).
The US-headquartered company of Israeli origin says its healthcare software solutions help in improving time-to-market of new products through clinical trial optimisation, event tracking, knowledge management, documentation, business intelligence and data warehousing, planning and budgeting.
What the reforms entail
The US healthcare reforms bill, which was passed into a law in March, seeks to ensure that everyone comes under medical coverage. Mr Bandopadhyay said IT services opportunities will come up in ramping up front-end systems (registration, payments, maintenance of medical records etc).
BPO services will be required in processing bills and queries. Significant opportunities will also arise in the area of cloud computing as hospitals would not want to own lot of hardware their premises.
Ness Technologies, which has its largest delivery centre in India with 3,000 employees, has been working with clinical research firms, pharmaceutical and biotechnology firms for several years. Its clients in the healthcare space include Pfizer (NYSE:PFE) , Bristol-Myers Squibb (NYSE:BMY PR) (NYSE:BMY) , Sanofi-Aventis (NYSE:SNY) , Kaiser Permanente, Johnson & Johnson (NYSE:JNJ) and Quintiles.
Recent wins
Recently, the company won a $44-million public tender with the Ministry of Health of the Slovak Republic to provide the first phase (for a period of 24 months) of an ‘electronic healthcare services’ system. It has also bagged a four-year outsourcing contract to provide around-the-clock help desk services to Clalit Health Services, Israel’s largest healthcare management organisation.
New Jersey-headquartered Ness Technologies also has a development centre in Tel Aviv, Israel. The company expects to close this financial year with revenues of $575 million.
Source:http://www.istockanalyst.com/article/viewiStockNews/articleid/4430024
